Kep-X Syrup is a combination expectorant and bronchodilator formulation containing Guaifenesin (50mg/5ml), Terbutaline (1.25mg/5ml), and Bromhexine (4mg/5ml). It is indicated for the symptomatic relief of respiratory conditions characterized by excessive mucus production and bronchospasm, such as chronic bronchitis, asthma, and other obstructive airway diseases. Guaifenesin acts as an expectorant by thinning and loosening mucus in the airways, facilitating easier expectoration. Terbutaline, a selective beta-2 adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscle, thereby improving airflow and reducing wheezing and shortness of breath. Bromhexine serves as a mucolytic agent, breaking down mucus structure to enhance clearance from the respiratory tract. The synergistic action of these components aids in alleviating cough and improving respiratory function. Kep-X Syrup should be used as directed by a healthcare professional, with dosage adjusted according to patient age and severity of symptoms. Caution is advised in patients with cardiovascular disorders, hypertension, or hypersensitivity to any of the ingredients. Common side effects may include tremors, palpitations, gastrointestinal discomfort, and allergic reactions. Consultation with a physician is recommended before initiating therapy.